These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34109194)

  • 1. Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer.
    Shen Y; Xiong W; Gu Q; Zhang Q; Yue J; Liu C; Wang D
    Front Med (Lausanne); 2021; 8():654635. PubMed ID: 34109194
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
    Zhao Y; Gao Y; Xu X; Zhou J; Wang H
    BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
    Song Y; Yang K; Sun T; Tang R
    BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
    Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
    Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma.
    Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B
    Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
    Kong L; Liu P; Zheng M; Xue B; Liang K; Tan X
    Epigenomics; 2020 Mar; 12(6):507-524. PubMed ID: 32048534
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma.
    Ma M; Chen Y; Chong X; Jiang F; Gao J; Shen L; Zhang C
    Aging (Albany NY); 2021 Feb; 13(5):6999-7019. PubMed ID: 33638948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
    Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
    J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma.
    Wang B; Li M; Li R
    Front Oncol; 2023; 13():1169395. PubMed ID: 37091151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.
    Lin Y; Zhang W; Cao H; Li G; Du W
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32759821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
    Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
    Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
    Kim I; Choi S; Kim S
    BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.
    Ye C; Wang H; Li Z; Xia C; Yuan S; Yan R; Yang X; Ma T; Wen X; Yang D
    Transl Androl Urol; 2021 Jul; 10(7):3030-3045. PubMed ID: 34430406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
    El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating gene expression from DNA methylation and copy number variation: A deep learning regression model for multi-omics integration.
    Seal DB; Das V; Goswami S; De RK
    Genomics; 2020 Jul; 112(4):2833-2841. PubMed ID: 32234433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Similarity Regression Fusion Model for Integrating Multi-Omics Data to Identify Cancer Subtypes.
    Guo Y; Zheng J; Shang X; Li Z
    Genes (Basel); 2018 Jun; 9(7):. PubMed ID: 29933539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets.
    Luan M; Song F; Qu S; Meng X; Ji J; Duan Y; Sun C; Si H; Zhai H
    Oncol Lett; 2020 Oct; 20(4):58. PubMed ID: 32863893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
    Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
    Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immunotherapy and chemotherapy-related molecular subtypes in colon cancer by integrated multi-omics data analysis.
    Zhu J; Kong W; Huang L; Bi S; Jiao X; Zhu S
    Front Immunol; 2023; 14():1142609. PubMed ID: 37020539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.